The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis

• Egile Nagusiak: Guyu Zhang (Egilea), Yimin Zhu (Egilea), Chongdong Liu (Egilea), Guangming Chao (Egilea), Ran Cui (Egilea), Zhenyu Zhang (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background and objective Previous studies about the prognostic value of the HIPEC have yielded controversial results. Therefore, this study aims to assess the impact of HIPEC on patients with ovarian cancer. Results We included 13 comparative studies, and found that the overall survival (OS...